Genprex, Inc. Common Stock (GNPX) is a publicly traded Healthcare sector company. As of September 8, 2026, GNPX trades at $3.71 with a market cap of $2.87M and a P/E ratio of -0.20. GNPX moved +0.00% today. Year to date, GNPX is -90.91%; over the trailing twelve months it is -98.61%. Its 52-week range spans $3.37 to $1,210.00. Rallies surfaces GNPX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks GNPX insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $3.71 |
| Market Cap | $2.87M |
| P/E Ratio | -0.20 |
| EPS | $-17.40 |
| Dividend Yield | 0.00% |
| 52-Week High | $1,210.00 |
| 52-Week Low | $3.37 |
| Volume | 382 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-16.23M |
| Gross Margin | 0.00% |
GNPX analyst coverage data. Average price target: $0.00.